- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04585425
Music for Sleep-onset Insomnia
December 19, 2023 updated by: University of Aarhus
God Nat - God Dag. A Randomized Controlled Trial of Bedtime Music as Early Intervention for Sleep-onset Insomnia
The study is a randomized controlled trial evaluating the effect of bedtime music as an early intervention for sleep-onset insomnia in adults.
The investigators use a randomized controlled trial design with two parallel groups.
All participants receive sleep hygiene advice as standard treatment and participants in the intervention group are additionally asked to listen to a sleep playlist daily at bedtime.
Subjective and objective sleep measures are evaluated before and after the 4 weeks intervention period.
In addition, follow-up measures of subjective outcomes are assessed 4 weeks after the end of the intervention period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Aarhus University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Sleep-onset insomnia for 3-18 months
Exclusion Criteria:
- use of medications (benzodiazepines, z-drugs, antidepressive and anti-psychotic drugs)
- alcohol or substance abuse
- pregnant or breastfeeding women
- other sleep disorders (e.g. sleep apnea, restless leg syndrome, etc.)
- current psychiatric disorder or a history of psychotic disorders
- somatic disorders interfering with sleep (e.g. critical illness, pain disorders, neuro-degenerative disorders)
- shift work.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Control
Treatment as usual including sleep hygiene advice
|
Participants receive standard sleep hygiene advice.
|
|
Experimental: Intervention
Treatment as usual (sleep hygiene advice) and bedtime music listening
|
Participants receive standard sleep hygiene advice.
Participants in the intervention group listen to their preferred sleep playlist daily at bedtime for minimum 30 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia severity
Time Frame: Change from baseline to after the 4-week intervention period.
|
Measured with the Insomnia Severity Index, range 0-28 with higher scores indicating more severe insomnia.
|
Change from baseline to after the 4-week intervention period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep quality
Time Frame: Change from baseline to after the 4-week intervention period.
|
Measured with the Pittsburgh Sleep Quality Index, range 0-21 with higher scores indicating more sleep problems.
|
Change from baseline to after the 4-week intervention period.
|
|
Sleep initiation difficulties
Time Frame: Change from baseline to after the 4-week intervention period.
|
Difficulties initiating sleep as measured with Pittsburgh Sleep Quality Index subscale
|
Change from baseline to after the 4-week intervention period.
|
|
Objective sleep quality
Time Frame: Change from baseline to after the 4-week intervention period.
|
Objective sleep quality as measured with polysomnography
|
Change from baseline to after the 4-week intervention period.
|
|
Sleep-wake pattern
Time Frame: Change from baseline to after the 4-week intervention period.
|
Sleep-wake pattern as measured with wrist-actigraphy
|
Change from baseline to after the 4-week intervention period.
|
|
Quality of life
Time Frame: Change from baseline to after the 4-week intervention period.
|
Quality of life as measured with SF-36, range 0-100 with higher scores indicating better quality of life.
|
Change from baseline to after the 4-week intervention period.
|
|
Pre-sleep arousal
Time Frame: Change from baseline to after the 4-week intervention period.
|
Pre-sleep arousal as measured with the Pre-Sleep Arousal Scale, range 8-40 with higher scores indicating higher pre-sleep arousal.
|
Change from baseline to after the 4-week intervention period.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms
Time Frame: Change from baseline to after the 4-week intervention period.
|
Depressive symptoms as measured with Beck Depression Inventory II, range 0-63 with higher scores indicating more severe depression.
|
Change from baseline to after the 4-week intervention period.
|
|
Anxiety
Time Frame: Change from baseline to after the 4-week intervention period.
|
Anxiety as measured with the State-Trait Anxiety Inventory, range 0-80 with higher scores indicating more anxiety.
|
Change from baseline to after the 4-week intervention period.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Kira V Jespersen, PhD, University of Aarhus
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2021
Primary Completion (Actual)
April 10, 2023
Study Completion (Actual)
June 2, 2023
Study Registration Dates
First Submitted
September 29, 2020
First Submitted That Met QC Criteria
October 6, 2020
First Posted (Actual)
October 14, 2020
Study Record Updates
Last Update Posted (Estimated)
December 20, 2023
Last Update Submitted That Met QC Criteria
December 19, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M&I2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteRecruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
Shanghai Haiyan Pharmaceutical Technology Co.,...Completed
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
Clinical Trials on Sleep hygiene advice
-
University of BergenCompletedA Self-help Book for Insomnia Compared With Sleep Hygiene Advice in Patients Using Sleep MedicationsHypnotic; Sleep DisorderNorway
-
University of BergenCompletedInsomnia | Sleep ApneaNorway
-
Shifa International HospitalRecruitingPrediabetes | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Prediabetes or DiabetesPakistan
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
University of ChicagoRecruiting
-
Universidad Autónoma de YucatánNot yet recruitingMental Health | Sleep Quality | Students, MedicalMexico
-
Diskapi Yildirim Beyazit Education and Research...CompletedDiabetes Mellitus, Type 2 | Sleep HygieneTurkey
-
National Taiwan University HospitalCompleted
-
Region StockholmActive, not recruiting
-
University of MichiganCompleted